Leflunomide and Therapeutic response delayed - a phase IV clinical study of FDA data

Summary:

Therapeutic response delayed is reported only by a few people who take Leflunomide.

The phase IV clinical study analyzes which people take Leflunomide and have Therapeutic response delayed. It is created by eHealthMe based on reports of 67,544 people who have side effects while taking Leflunomide from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 22, 2023

67,544 people reported to have side effects when taking Leflunomide.
Among them, 4 people (0.01%) have Therapeutic response delayed.

What is Leflunomide?

Leflunomide has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 67,910 Leflunomide users for its effectiveness, alternative drugs and more.

What is Therapeutic response delayed?

Therapeutic response delayed (late preventive response) is found to be associated with 633 drugs and 342 conditions by eHealthMe.

Number of Leflunomide and Therapeutic response delayed reports submitted per year:

Could Leflunomide cause Therapeutic response delayed?

Gender of people who have Therapeutic response delayed when taking Leflunomide *:

female: 100 %
male: 0.0 %

Common drugs people take besides Leflunomide *:

Common side effects people have besides Therapeutic response delayed *:

Joint Pain: 2 people, 50.00%
Upper Limb Fracture: 1 person, 25.00%
Injection Site Extravasation (flow of (blood or lymph) from injection site): 1 person, 25.00%
Diarrhea: 1 person, 25.00%
Eye Injury: 1 person, 25.00%
Fatigue (feeling of tiredness): 1 person, 25.00%
Gait Disturbance: 1 person, 25.00%
Headache (pain in head): 1 person, 25.00%
Hypoaesthesia (reduced sense of touch or sensation): 1 person, 25.00%
Insomnia (sleeplessness): 1 person, 25.00%

Common conditions people have *:

Eye Disorder: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Leflunomide and have Therapeutic response delayed?

Check whether Therapeutic response delayed is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Therapeutic response delayed and when was it recovered:

Therapeutic response delayed in Leflunomide

Expand to all the drugs that have ingredients of leflunomide:

Therapeutic response delayed and drugs with ingredients of leflunomide

Alternative drugs to, pros and cons of Leflunomide:

Leflunomide (67,910 reports)

Common Leflunomide side effects:

Drug ineffective: 30,964 reports
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 19,759 reports
Pain: 13,190 reports
Joint swelling: 12,445 reports
Joint pain: 11,761 reports
Rashes (redness): 10,266 reports
Fatigue (feeling of tiredness): 9,884 reports

Browse all side effects of Leflunomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Therapeutic response delayed treatments and more:

Therapeutic response delayed (2,513 reports)

COVID vaccines that are related to Therapeutic response delayed:

Common drugs associated with Therapeutic response delayed:

Enbrel: 324 reports
Oxycontin: 140 reports

All the drugs that are associated with Therapeutic response delayed:

Therapeutic response delayed (633 drugs)

Common conditions associated with Therapeutic response delayed:

Rheumatoid arthritis: 233 reports
Psoriasis: 163 reports
Pain: 151 reports

All the conditions that are associated with Therapeutic response delayed:

Therapeutic response delayed (342 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on leflunomide (the active ingredients of Leflunomide) and Leflunomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.